Cancer glycomics explores changes in glycan structures associated with tumor development and progression. By analyzing glycosylation patterns on proteins and cells, researchers can identify biomarkers for early cancer detection and monitor treatment responses. Advanced techniques like mass spectrometry and glycan microarrays enable precise profiling, offering insights into tumor biology and supporting the development of targeted diagnostics and personalized therapies.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek